Explain the mechanism of acute respiratory distress syndrome
Reading File
Finding Sources
Finding Sources
Searching PubMed
"acute respiratory distress syndrome"[MeSH Terms] AND pathogenesis
Reading File
Reading File
Reading File
Reading File
Reading File
Searching Images
acute respiratory distress syndrome pathogenesis mechanism diagram
Reading File
Loading Image
I have all the necessary textbook content. Let me now compile a comprehensive answer.
Acute Respiratory Distress Syndrome (ARDS): Mechanism
Definition & Overview
ARDS is a syndrome of acute-onset, non-cardiogenic pulmonary edema caused by increased alveolar-capillary permeability, leading to protein-rich exudative fluid flooding the alveolar spaces. Unlike cardiogenic pulmonary edema (driven by elevated hydrostatic pressure), ARDS edema is caused by barrier disruption, not pressure. It produces severe hypoxemia, markedly reduced lung compliance, and high dead-space ventilation.
The Berlin Definition classifies ARDS by P/F ratio: mild (200–300), moderate (100–200), and severe (<100 mmHg), all requiring ≥5 cmH₂O PEEP. Mortality commonly exceeds 30–40%.
Triggers: Direct vs. Indirect Injury
| Direct (Pulmonary) | Indirect (Non-Pulmonary) |
|---|---|
| Pneumonia (bacterial, viral, COVID-19) | Sepsis |
| Aspiration of gastric contents | Major trauma |
| Pulmonary contusion | Multiple blood transfusions |
| Toxic inhalation | Pancreatitis |
| Near-drowning | Cardiopulmonary bypass |
| Reperfusion injury (post-lung transplant) | Drug overdose |
Sepsis, major trauma, aspiration, and massive transfusions carry the highest individual risks. Combinations of risk factors multiply the incidence significantly. — Murray & Nadel's Textbook of Respiratory Medicine
Pathogenesis: Step-by-Step
1. Initiating Injury — Activation of Innate Immunity
The cascade begins when a direct or systemic insult activates the innate immune system. Pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) engage pattern recognition receptors (PRRs), triggering macrophage and epithelial activation. Alveolar macrophages release TNF-α, IL-1β, IL-6, IL-8, and other pro-inflammatory cytokines that initiate the downstream cascade.
2. Neutrophil Recruitment and Activation — The Central Effector Mechanism
Neutrophils are the primary effector cells of ARDS. Under the influence of IL-8, LTB4, and C5a, circulating neutrophils:
- Marginate in the pulmonary microcirculation
- Adhere to activated endothelium via upregulated adhesion molecules (E-selectin, ICAM-1, β2 integrins)
- Transmigrate into the alveolar interstitium and airspace
Activated neutrophils then release:
- Reactive oxygen species (ROS) — cause oxidative membrane damage
- Proteases (elastase, matrix metalloproteinases) — digest basement membrane and tight junction proteins
- Neutrophil extracellular traps (NETs) — formed by histone/DNA complexes; trigger further endothelial and epithelial injury
- Platelet-activating factor (PAF) — amplifies inflammation and promotes microvascular thrombosis
Evidence: BAL fluid from ARDS patients contains markedly elevated neutrophil counts even though normal BAL fluid contains very few. — Murray & Nadel's Textbook of Respiratory Medicine
3. Alveolar-Capillary Barrier Disruption
The alveolar-capillary unit has two layers:
- Microvascular endothelium — maintains vascular integrity
- Alveolar epithelium — comprised of type I pneumocytes (95% of surface area; gas exchange, thin) and type II pneumocytes (surfactant production, proliferative capacity)
In ARDS, both layers are injured:
Endothelial injury:
- Cytokines and oxidants disrupt intercellular tight junctions and gap junctions
- Loss of endothelial barrier → protein-rich fluid leaks from capillaries into the interstitium and alveoli
- Vascular smooth muscle tone is impaired → pulmonary hypertension via hypoxic vasoconstriction and intravascular fibrin deposition
Epithelial injury:
- Type I pneumocytes are highly vulnerable and undergo necrosis/apoptosis early
- Loss of type I cells strips the alveolar surface, allowing further fluid ingress
- Type II pneumocyte injury impairs surfactant synthesis and secretion, worsening alveolar collapse
4. Surfactant Dysfunction
Injury to type II pneumocytes and the presence of protein-rich flood in the alveoli inactivates surfactant. Phospholipase A₂ (released during pancreatitis and other insults) enzymatically degrades surfactant phospholipids. Without surfactant's surface-tension-lowering effect, alveoli collapse (atelectasis) → increased intrapulmonary shunt → refractory hypoxemia.
5. Hyaline Membrane Formation — Diffuse Alveolar Damage (DAD)
The exudative protein floods the airspaces and, combined with cellular debris and fibrin, forms hyaline membranes — the histologic hallmark of DAD. These membranes line the alveolar walls, further reducing gas exchange area. DAD is found on autopsy/biopsy in approximately 50% of ARDS patients (those with DAD are more severely ill with higher mortality). — Murray & Nadel's Textbook of Respiratory Medicine
6. Coagulation Activation and Microvascular Thrombosis
Endothelial injury and activated platelets trigger the coagulation cascade within pulmonary microvessels. Fibrin thrombi occlude capillaries, increasing dead-space ventilation and pulmonary vascular resistance. Plasminogen activator inhibitor-1 (PAI-1) is markedly elevated, suppressing fibrinolysis and promoting clot persistence. This coagulopathy contributes to pulmonary hypertension and further tissue ischemia.
The Three Pathologic Phases
| Phase | Timing | Key Features |
|---|---|---|
| Exudative | Days 1–7 | Hyaline membranes, protein-rich edema, neutrophilic infiltration, DAD |
| Proliferative | Days 7–21 | Hyaline membrane organization, type II pneumocyte proliferation, early fibrosis, decreasing edema |
| Fibrotic | >2–3 weeks (subset) | Pulmonary fibrosis, obliteration of alveolar architecture, chronic respiratory impairment |
Notably, elevated N-terminal procollagen peptide III in BAL fluid can be detected as early as 24 hours after ARDS onset, suggesting fibroproliferation begins simultaneously with (not after) the inflammatory injury — not sequentially as classically described. BAL fluid from ARDS patients actively stimulates fibroblast proliferation in vitro. — Murray & Nadel's Textbook of Respiratory Medicine
Pathophysiologic Consequences
| Consequence | Mechanism |
|---|---|
| Refractory hypoxemia | Right-to-left shunt from flooded, atelectatic alveoli with continued perfusion; low V/Q units |
| Reduced lung compliance | Alveolar flooding, surfactant loss, and hyaline membrane formation increase stiffness |
| Increased dead space | Microvascular occlusion → ventilated but unperfused alveoli; increases minute ventilation requirement |
| Pulmonary hypertension | Hypoxic vasoconstriction, fibrin microthrombi, compression by positive-pressure ventilation |
| Bilateral infiltrates | Gravity-dependent fluid accumulation; "baby lung" concept — only ~30% of aerated lung remains |
ARDS Subphenotypes (Biological Heterogeneity)
Latent class analysis of large ARDSNet trials reveals two reproducible subphenotypes:
- Subphenotype 1 (Hypoinflammatory): Low IL-6, IL-8, TNF-sR1, PAI-1; higher BP; more trauma-associated; lower mortality (~25%)
- Subphenotype 2 (Hyperinflammatory): High inflammatory markers; hypotension, tachycardia, sepsis-associated; higher mortality (~50%)
These phenotypes respond differently to PEEP levels and fluid management strategies, highlighting that ARDS is not a single disease but a syndrome with distinct molecular endotypes. — Murray & Nadel's Textbook of Respiratory Medicine
Genetic and Molecular Modifiers
- ACE2 receptor: SARS-CoV-1 and SARS-CoV-2 both bind ACE2, reducing its expression. Since ACE2 degrades angiotensin II (a pro-inflammatory, pro-fibrotic mediator), its depletion amplifies lung injury — a pathway now central to COVID-19-associated ARDS.
- Chronic alcoholism doubles the risk of ARDS (relative risk 2.0), likely via impaired antioxidant defenses (glutathione depletion) and altered neutrophil function.
- Cigarette smoke exposure associates with trauma-related ARDS through oxidant-mediated endothelial priming.
Summary Diagram of the Core Mechanism
Systemic/Direct Insult (sepsis, pneumonia, trauma, aspiration)
↓
Innate Immune Activation → Macrophages release TNF-α, IL-1β, IL-6, IL-8
↓
Neutrophil Recruitment → Margination → Adhesion → Transmigration
↓
ROS + Proteases + NETs + PAF
↓
Endothelial & Epithelial Barrier Breakdown
↓ ↓
Protein-rich Edema Type II Pneumocyte Injury
floods alveoli → Surfactant dysfunction
↓ ↓
Hyaline Membrane Formation Alveolar Collapse (Atelectasis)
↓ ↓
DAD (Diffuse Alveolar Damage) ←────────┘
↓
Shunt + Low V/Q + Dead Space + Pulmonary HTN
↓
Hypoxemic Respiratory Failure (ARDS)
The mechanism of ARDS is fundamentally one of uncontrolled innate immune activation converging on the alveolar-capillary interface, with neutrophil-mediated oxidant and protease injury driving barrier failure, surfactant loss, and exudative flooding — ultimately producing the severe gas-exchange failure that defines the syndrome.
This is a shared conversation. Sign in to Orris to start your own chat.